Phase ii study of irinotecan in combination with capecitabine on a 3-weekly schedule as first-line chemotherapy for patients with metastatic or locally advanced colorectal cancer
- Salud, A.
- Alonso, V.
- Escudero, P.
- Burillo, M.
- Martín, C.
- Rivera, F.
- Yubero, A.
- García-Girón, C.
- Muñoz, A.
ISSN: 1927-7229, 1927-7210
Année de publication: 2013
Volumen: 2
Número: 3
Pages: 151-159
Type: Article
